Health
Global AIDS fund approves use of generic anti-HIV drugs
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Global AIDS fund approves use of generic anti-HIV drugs
Global AIDS fund approves use of generic anti-HIV drugs
On Tuesday the Global Fund to Fight AIDS, Tuberculosis, and Malaria urged developing countries receiving money from the fund to buy cheap generic anti-HIV medications instead of the more costly brand-name drugs, The New York Times reports. The fund asks that programs receiving funds buy the lowest-priced drugs available that meet guaranteed quality standards. Any drug on the World Health Organization's new list of approved drugs, which include several generic anti-HIV medications, automatically qualifies for the program. Other generic drugs will be evaluated on a case-by-case basis. The decision opens the door for generic anti-HIV drugmakers in India, Brazil, and other countries to sell their products throughout the world. "It's a big step forward," said Richard Feachem, executive director of the fund, explaining that the decision will help stretch the fund's resources. The announcement by the global fund was met with a surprising endorsement from the Pharmaceutical Research and Manufacturers of America, a trade group that historically has opposed the creation of generic versions of patented anti-HIV medications. "We believe strongly that there is room for bona fide generics as long as they are of high quality," said group spokesperson Shannon Herzfeld.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!